发明名称 |
Compounds as histamine H3 receptor ligands |
摘要 |
The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them.;;The present invention also relates to a process for the preparation of above compounds of formula (I), and their pharmaceutically acceptable salts.;The compounds of formula (I) are useful in the treatment of various disorders that are related to Histamine H3 receptors. |
申请公布号 |
US9079888(B2) |
申请公布日期 |
2015.07.14 |
申请号 |
US201114000362 |
申请日期 |
2011.06.07 |
申请人 |
Suven Life Sciences Limited |
发明人 |
Nirogi Ramakrishna;Shinde Anil Karbhari;Kambhampati Ramasastri;Deshpande Amol Dinakar;Dwarampudi Adi Reddy;Gangadasari Narasimhareddy;Saraf Sangram Keshari;Kandikere Vishwottam Nagaraj;Jayarajan Pradeep;Ahmad Ishtiyaque;Mulla Mohmadsadik Abdulhamid;Jasti Venkateswarlu |
分类号 |
C07D401/12;C07D405/12;C07D413/12;C07D401/14;C07D211/46 |
主分类号 |
C07D401/12 |
代理机构 |
IpHorgan Ltd. |
代理人 |
IpHorgan Ltd. |
主权项 |
1. A compound of the general formula (I):wherein,
at each occurrence, R1 is independently selected from hydrogen, hydroxy, hydroxyalkyl, halogen, alkyl, alkoxy, haloalkyl, haloalkoxy, cyano or —C(O)—NH2; L is alkyl or X is C, O or N—R2; Y is C or N; A is —C(O)— or —CH2; R2 is hydrogen, alkyl, —C(O)-alkyl or —S(O)2-alkyl; “r” is 0 or 1; “p” is an integer ranging from 0 to 3;or a pharmaceutically acceptable salt thereof. |
地址 |
Hyderabad IN |